Bioheart (02185.HK) anuncia resultado clínico do Iberis-HTN na CIT 2023 ...Middle East

XANGAI, 2 de julho de 2023 /PRNewswire/ -- A Bioheart (02185.HK), juntamente com sua subsidiária holding Angiocare, anuncia o resultado clínico do Iberis-HTN na China Interventional Therapeutics 2023. O Iberis-HTN é um estudo clínico prospectivo, multicêntrico, cego e randomizado para...

Hence then, the article about bioheart 02185 hk anuncia resultado clinico do iberis htn na cit 2023 was published today ( Sunday 02/07/2023 - 11:33 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Bioheart (02185.HK) anuncia resultado clínico do Iberis-HTN na CIT 2023 )

Also on site :

• John Legend Celebrates 47th Birthday With Family Slime Outing in New York
• Kurtenbach: These unbelievable 49ers might just be a team of destiny
• United Site Services Reaches Agreement with Key Financial Stakeholders to Position Company for Future Success